IBIO 주식 스냅샷
가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$1.45
시가총액
$28M
P/E (TTM)
-0.8
EPS (TTM)
$-1.75
매출 (TTM)
$400.0K
배당 수익률
—
ROE
-101.5%
부채/자본
0.1
52주 범위
$1 – $3
IBIO 주가 차트
기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
이동 평균 및 오버레이
거래량
오실레이터
모멘텀 및 추세
Configure
10년 성과
매출, 순이익, 마진 및 EPS 추세
매출 및 순이익$400.0K
2020-06-30→2025-06-30
EPS$-1.75
2021-06-30→2025-06-30
잉여현금흐름$-15M
2021-06-30→2025-06-30
마진-4594.2%
2021-06-30→2022-06-30
가치 평가
P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
IBIO
동종업계 중앙값
P/E (TTM)
-0.8
4.7
P/S (TTM)
70.1
31.0
P/B
1.9
1.8
EV / EBITDA
-1.1
—
Price / FCF (주가 / FCF)
-1.8
—
수익성
총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
IBIO
동종업계 중앙값
Operating Margin (영업이익률)
-4650.5%
—
Net Profit Margin (순이익률)
-4594.2%
-1601.1%
ROA
-70.8%
-68.1%
ROE
-101.5%
-111.7%
재무 건전성
부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
IBIO
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
0.1
0.0
Current Ratio (유동비율)
1.6
4.1
Quick Ratio (당좌 비율)
1.4
—
성장
매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
IBIO
동종업계 중앙값
Revenue YoY (매출 YoY)
77.8%
—
Revenue CAGR 3Y (매출 CAGR 3년)
-40.3%
—
Revenue CAGR 5Y (매출 CAGR 5년)
-24.6%
—
주당 지표
EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금
지표
5년 추세
IBIO
동종업계 중앙값
EPS (Diluted) (EPS (희석))
$-1.75
—
자본 효율성
자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
IBIO
동종업계 중앙값
IBIO 분석가 합의
강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수14 명의 애널리스트
적극 매수
428.6%
매수
964.3%
보유
17.1%
매도
00.0%
적극 매도
00.0%
12개월 목표 주가
8 명의 애널리스트
· 2026-08-13
중앙값$5.00
평균$5.40
← 모든 목표가 하회
$1.45
저가$4.20
고가$7.00
중앙값 목표$5.00
+244.8%
평균 목표$5.40
+272.4%
실적 기록
EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.05%
다음 실적
9월 03, 2026
기간
EPS Actual
EPS 예상
서프라이즈
2026년 3월 31일
$-0.06
$-0.06
0.00%
2025년 12월 31일
$-0.09
$-0.08
-0.01%
2025년 9월 30일
$-0.11
$-0.10
-0.01%
2025년 6월 30일
$-0.49
$-0.37
-0.12%
2025년 3월 31일
$-0.49
$-0.37
-0.12%
동종 기업 비교(GICS 하위 산업)
주요 지표 대 섹터 동종 기업
티커
시가총액
P/E
매출 YoY
순이익률
ROE
매출 총이익률
IBIO
$15M
-0.4
77.8%
-4594.2%
-101.5%
—
FRMM
—
—
—
-6881.3%
-368.1%
—
ANVS
$94M
-2.5
—
—
-164.0%
—
CYPH
$97M
16.6
—
—
6.1%
—
NMAD
—
—
—
—
—
—
RNTX
—
-0.6
—
—
—
—
DWTX
$124M
-0.6
123.6%
—
-83.8%
—
CRDF
$192M
-4.1
-13.2%
-7732.0%
-88.2%
—
SPRO
$131M
15.5
39.2%
12.8%
18.7%
—
GOSS
$724M
-4.1
-57.7%
-351.5%
201.8%
—
전체 기본 지표
연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서17
IBIO의 연간 손익계산서 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
$400.0K
$225.0K
$0
$2M
$2M
$2M
$2M
$444.0K
$394.0K
$948.0K
$2M
$205.0K
Cost of Revenue
·
·
·
$216.0K
$1M
$703.0K
·
·
·
·
·
·
Gross Profit
·
·
·
$2M
$909.0K
$935.0K
·
·
·
·
·
·
R&D Expense
$8M
$5M
$10M
$10M
$10M
$4M
$5M
$4M
$4M
$3M
$3M
$2M
SG&A Expense
$11M
$12M
$19M
$22M
$22M
$11M
$12M
$11M
$11M
$8M
$5M
$4M
Operating Expenses
$19M
$17M
$29M
$32M
$32M
$15M
$18M
$15M
$15M
$11M
$9M
$4M
Operating Income
$-19M
$-17M
$-29M
$-30M
$-31M
$-14M
$-16M
$-14M
$-14M
$-10M
$-7M
$-4M
Interest Expense
·
·
$83.0K
$1M
$2M
$2M
$2M
$2M
$2M
$807.0K
$0
$0
Interest Income
$437.0K
$363.0K
$213.0K
$177.0K
$140.0K
$15.0K
$75.0K
$15.0K
$39.0K
$22.0K
$9.0K
$8.0K
Other Non-op
$225.0K
$1M
$32.0K
$184.0K
$8M
$-2M
$-2M
$-2M
$-2M
$-764.0K
$41.0K
$3.0K
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-18M
$-25M
$-65M
$-50M
$-23M
$-16M
$-18M
$-16M
$-15M
$-10M
$-7M
$-4M
EPS (Basic)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
EPS (Diluted)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
Shares (Basic)
10,499,000
3,831,000
612,000
8,721,000
7,825,000
·
·
·
·
·
·
·
Shares (Diluted)
10,499,000
3,831,000
612,000
8,721,000
7,825,000
·
·
·
·
·
·
·
EBITDA
$-19M
$-17M
$-29M
$-50M
$-31M
·
$-16M
$-14M
$-14M
$-10M
$-7M
·
대차대조표24
IBIO의 연간 대차대조표 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Cash & Equivalents
$9M
$14M
$4M
$23M
$77M
$55M
$4M
$4M
$16M
$16M
$9M
$4M
Receivables
·
$0
$0
$1M
$426.0K
$75.0K
$97.0K
$75.0K
$175.0K
$484.0K
$445.0K
$205.0K
Inventory
·
$0
$0
$4M
$27.0K
·
·
·
·
·
·
·
Prepaid Expense
$1M
$749.0K
$664.0K
$2M
$2M
$214.0K
$290.0K
$276.0K
$283.0K
$264.0K
$182.0K
$118.0K
Other Current Assets
·
·
·
·
·
·
·
·
·
·
$17.0K
$8.0K
Current Assets
$10M
$16M
$26M
$45M
$105M
$62M
$5M
$16M
$9M
$24M
$10M
$4M
PP&E (Net)
$3M
$4M
$4M
$1M
$9M
$4M
$24M
$25M
$26M
$26M
$13.0K
$6.0K
PP&E (Gross)
$5M
$5M
$5M
$1M
$10M
$4M
$29M
$28M
$27M
$26M
$40.0K
·
Accum. Depreciation
$1M
$1M
$400.0K
$0
$1M
$753.0K
$5M
$3M
$2M
$605.0K
$27.0K
·
Intangibles
$7M
$5M
$5M
$5M
$952.0K
$1M
$1M
$2M
$2M
$2M
$2M
$3M
Total Assets
$23M
$29M
$41M
$99M
$147M
$94M
$31M
$43M
$36M
$52M
$12M
$6M
Accounts Payable
$2M
$358.0K
$2M
$4M
$2M
$2M
$1M
$790.0K
$749.0K
$1M
$1M
$297.0K
Accrued Liabilities
$1M
$2M
$5M
$4M
$3M
$1M
$965.0K
$1M
$924.0K
$920.0K
$159.0K
$98.0K
Short-term Debt
$766.0K
$218.0K
$13M
$22M
$600.0K
$261.0K
$0
·
·
·
·
·
Current Liabilities
$6M
$4M
$22M
$30M
$7M
$5M
$3M
$2M
$2M
$2M
$1M
$395.0K
Capital Leases
$2M
$3M
$3M
$4M
$0
$0
$25M
$25M
$25M
$25M
$0
·
Total Liabilities
$8M
$7M
$26M
$36M
$38M
$38M
$28M
$27M
$27M
$28M
$1M
$395.0K
Total Debt
$766.0K
$218.0K
$13M
$22M
$600.0K
·
·
·
·
·
·
·
Common Stock
$19.0K
$9.0K
$1.0K
$9.0K
$9.0K
$140.0K
$20.0K
$16.0K
$9.0K
$89.0K
$77.0K
$66.0K
Retained Earnings
$-332M
$-314M
$-289M
$-224M
$-174M
$-150M
$-106M
$-88M
$-72M
$-58M
$-48M
$-41M
AOCI
·
·
·
$-213.0K
$-63.0K
$-33.0K
$-31.0K
$-30.0K
$-29.0K
$-29.0K
$-25.0K
$0
Stockholders' Equity
$15M
$21M
$15M
$63M
$109M
$57M
$2M
$16M
$9M
$10M
$11M
$6M
Liabilities + Equity
$23M
$29M
$41M
$99M
$147M
$94M
$31M
$43M
$36M
$52M
$12M
$6M
Shares Outstanding
19,349,201
8,623,676
1,015,505
8,727,158
8,714,924
140,071,110
20,152,458
16,040,126
8,911,851
89,109,410
77,205,410
65,642,095
현금 흐름12
IBIO의 연간 현금 흐름 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
D&A
·
·
·
·
·
·
$179.0K
·
·
·
·
·
Stock-based Comp
$2M
$2M
$4M
$4M
$2M
$388.0K
$241.0K
$770.0K
$1M
$1M
$914.0K
$1M
Deferred Tax
$-9M
$-5M
$-13M
·
·
·
·
·
·
·
·
·
Amort. of Intangibles
$20.0K
$20.0K
$126.0K
$401.0K
$291.0K
$298.0K
$322.0K
$341.0K
$350.0K
$363.0K
$358.0K
$358.0K
Operating Cash Flow
$-15M
$-19M
$-30M
$-37M
$-30M
$-13M
$-14M
$-13M
$-13M
$-8M
$-5M
$-4M
CapEx
$16.0K
$210.0K
$6M
$7M
$5M
$1M
$920.0K
$934.0K
$1M
$68.0K
$13.0K
$4.0K
Investing Cash Flow
$742.0K
$906.0K
$7M
$-5M
$-26M
$-1M
$-990.0K
$-1M
$-2M
·
·
·
Stock Issued
$4M
$26M
$11M
·
·
·
·
·
$0
$6M
$10M
$480.0K
Net Stock Activity
$4M
$26M
·
·
·
·
·
·
$0
$6M
$10M
·
Financing Cash Flow
$9M
$24M
$2M
$-6M
$79M
$65M
$3M
$22M
$-170.0K
·
·
·
Net Change in Cash
$-6M
$7M
$-21M
$-49M
$22M
$51M
$-12M
$8M
$-15M
$14M
$6M
$-824.0K
Free Cash Flow
$-15M
$-19M
$-36M
$-45M
$-35M
·
$-15M
$-14M
$-14M
$-8M
$-5M
·
수익성6
IBIO의 연간 수익성 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Gross Margin
·
·
·
90.9%
38.3%
·
·
·
·
·
·
·
Operating Margin
-4650.5%
-7392.9%
·
-2085.2%
-1312.1%
·
-782.4%
-3204.3%
-3622.8%
-1043.6%
-360.1%
·
Net Margin
-4594.2%
-11069.8%
·
-2110.9%
-978.8%
·
-871.8%
-3627.2%
-3688.3%
-1030.0%
-357.9%
·
EBITDA Margin
-4650.5%
-7392.9%
·
-2085.2%
-1312.1%
·
-782.4%
-3204.3%
-3622.8%
-1043.6%
-360.1%
·
ROA
-70.8%
-71.2%
-92.5%
-40.8%
-16.0%
·
-53.1%
-43.5%
-37.9%
-19.1%
-69.8%
·
ROE
-101.5%
-135.7%
-164.9%
-58.5%
-28.1%
·
-188.9%
-128.4%
-154.2%
-92.2%
-76.5%
·
유동성 및 지급능력4
IBIO의 연간 유동성 및 지급능력 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Current Ratio
1.6
4.1
1.2
1.5
15.7
·
1.4
8.0
4.3
10.4
·
·
Quick Ratio
1.4
3.7
0.2
0.8
11.7
·
1.3
7.9
4.1
10.3
·
·
Debt / Equity
0.1
0.0
0.8
0.3
0.0
·
·
·
·
·
·
·
Interest Coverage
·
·
-353.5
-35.2
-12.7
·
-8.3
-7.4
-7.4
-12.3
·
·
효율성3
IBIO의 연간 효율성 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Asset Turnover
0.0
0.0
0.0
0.0
0.0
·
0.1
0.0
0.0
0.0
0.2
·
Inventory Turnover
·
·
·
0.1
·
·
·
·
·
·
·
·
Receivables Turnover
·
·
·
3.3
9.5
·
23.5
3.6
1.2
2.0
5.7
·
주당5
IBIO의 연간 주당 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Book Value / Share
$0.77
$2.47
$0.76
$7.27
$0.50
·
$0.12
$1.01
$0.10
$0.11
$0.15
·
Revenue / Share
$0.04
$0.06
$0.00
$0.27
·
·
·
·
·
·
·
·
Cash Flow / Share
$-1.46
$-4.84
$-2.49
$-4.30
·
·
·
·
·
·
·
·
Cash / Share
$0.44
$1.65
$0.21
$2.60
$0.36
·
$0.22
$0.99
$0.09
$0.26
$0.12
·
EPS (TTM)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
성장률3
IBIO의 연간 성장률 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue YoY
77.8%
·
·
-20.5%
44.8%
·
·
·
·
·
·
·
Revenue CAGR 3Y
-40.3%
-54.4%
·
·
·
·
·
·
·
·
·
·
Revenue CAGR 5Y
-24.6%
·
·
·
·
·
·
·
·
·
·
·
가치 평가 (TTM)14
IBIO의 연간 가치 평가 (TTM) 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue TTM
$400.0K
$225.0K
$0
$2M
$2M
$2M
$2M
$444.0K
$394.0K
$948.0K
$2M
$205.0K
Net Income TTM
$-18M
$-25M
$-65M
$-50M
$-23M
$-16M
$-18M
$-16M
$-15M
$-10M
$-7M
$-4M
Market Cap
$15M
$18M
$248M
$1.13B
$164.49B
·
$7.15B
$7.22B
$173.78B
$320.79B
$366.73B
·
Enterprise Value
$7M
$4M
$256M
$1.13B
$164.42B
·
·
·
·
·
·
·
P/E
-0.4
-0.3
-0.1
-22.5
-251.7
·
·
·
·
·
·
·
P/S
36.8
80.9
·
602.2
69377.6
·
3545.2
16256.9
441068.8
338390.2
198123.0
·
P/B
1.0
0.9
16.1
17.9
1514.9
·
2904.6
446.5
19495.3
32282.8
32653.0
·
P / Tangible Book
1.8
1.1
24.8
19.3
1528.3
2802.7
·
·
·
·
·
·
P / Cash Flow
-1.0
-1.0
-8.1
-30.3
-5471.5
·
-511.9
-535.5
-13202.2
-39741.6
-77613.9
·
P / FCF
-1.0
-1.0
-6.8
-25.3
-4702.0
·
-480.3
-500.8
-11996.5
-39409.6
-77400.9
·
EV / EBITDA
-0.4
-0.3
-8.7
-22.8
-5284.9
·
·
·
·
·
·
·
EV / FCF
-0.4
-0.2
-7.1
-25.3
-4699.8
·
·
·
·
·
·
·
EV / Revenue
17.2
18.7
·
601.9
69345.2
·
·
·
·
·
·
·
Earnings Yield
-230.3%
-308.1%
-870.4%
-4.5%
-0.40%
·
·
·
·
·
·
·
손익계산서15
IBIO의 분기별 손익계산서 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Revenue
$0
$0
$100.0K
$200.0K
$0
$200.0K
$0
$175.0K
$0
$0
$50.0K
$0
$0
$0
$0
$0
R&D Expense
$3M
$4M
$4M
$3M
$2M
$2M
$1M
$1M
$904.0K
$2M
$2M
$2M
$3M
$3M
$3M
$4M
SG&A Expense
$5M
$5M
$3M
$2M
$3M
$3M
$3M
$2M
$3M
$3M
$4M
$3M
$4M
$8M
$5M
$7M
Operating Expenses
$8M
$9M
$6M
$5M
$5M
$5M
$4M
$4M
$4M
$4M
$5M
$5M
$6M
$11M
$8M
$10M
Operating Income
$-8M
$-9M
$-6M
$-5M
$-5M
$-4M
$-4M
$-3M
$-4M
$-4M
$-5M
$-5M
$-6M
$-11M
$-8M
$-10M
Interest Expense
·
·
·
·
·
·
·
·
$52.0K
$34.0K
$26.0K
·
$35.0K
$31.0K
·
·
Interest Income
$657.0K
$493.0K
$267.0K
$79.0K
$72.0K
$112.0K
$174.0K
$223.0K
$43.0K
$42.0K
$55.0K
$50.0K
$23.0K
$41.0K
$99.0K
$66.0K
Other Non-op
$635.0K
$452.0K
$231.0K
$35.0K
$18.0K
$55.0K
$117.0K
$163.0K
$991.0K
$8.0K
$29.0K
$33.0K
$-110.0K
$10.0K
$99.0K
$68.0K
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-8M
$-9M
$-6M
$-5M
$-5M
$-4M
$-4M
$-8M
$-3M
$-8M
$-6M
$-6M
$-7M
$-34M
$-18M
$-17M
EPS (Basic)
$-0.06
$-0.09
$-0.11
$-0.32
$-0.49
$-0.48
$-0.46
$3.57
$-0.85
$-4.42
$-4.80
$-24.64
$-11.07
$-68.43
$-2.05
$-1.96
EPS (Diluted)
$-0.06
$-0.09
$-0.11
$-0.32
$-0.49
$-0.48
$-0.46
$3.57
$-0.85
$-4.42
$-4.80
$-24.64
$-11.07
$-68.43
$-2.05
$-0.59
Shares (Basic)
119,600,000
99,133,000
52,981,000
-17,128,000
9,862,000
9,132,000
8,633,000
-2,936,000
3,713,000
1,856,000
1,198,000
-9,379,000
659,000
490,000
8,842,000
-17,428,000
Shares (Diluted)
119,600,000
99,133,000
52,981,000
-17,128,000
9,862,000
9,132,000
8,633,000
-2,936,000
3,713,000
1,856,000
1,198,000
-9,379,000
659,000
490,000
8,842,000
-17,428,000
EBITDA
$-8M
$-9M
$-6M
·
$-5M
$-4M
$-4M
·
$-4M
$-4M
$-5M
·
$-6M
$-11M
$-8M
·
대차대조표23
IBIO의 분기별 대차대조표 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Cash & Equivalents
$48M
$29M
$28M
$9M
$5M
$7M
$11M
$14M
$5M
$3M
$1M
$4M
$7M
$4M
$10M
$23M
Receivables
·
·
$65.0K
·
·
·
·
·
·
·
$0
·
$70.0K
$970.0K
$1M
$1M
Inventory
·
·
·
·
·
·
·
·
$0
$0
$0
$0
·
·
·
$4M
Prepaid Expense
$2M
$670.0K
$1M
$1M
$1M
$1M
$667.0K
$749.0K
$862.0K
$894.0K
$451.0K
$664.0K
$921.0K
$414.0K
$1M
$2M
Current Assets
$77M
$53M
$51M
$10M
$6M
$8M
$12M
$16M
$36M
$20M
$23M
$26M
$27M
$38M
$64M
$45M
PP&E (Net)
$3M
$3M
$3M
$3M
$3M
$3M
$4M
$4M
$4M
$4M
$4M
$4M
$4M
$4M
$3M
$1M
PP&E (Gross)
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$4M
·
$1M
Accum. Depreciation
$2M
$2M
$2M
$1M
$1M
$1M
$1M
$1M
$893.0K
$729.0K
$565.0K
$400.0K
$235.0K
$115.0K
·
$0
Intangibles
$2M
$4M
$7M
$7M
$6M
$6M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$6M
$5M
Total Assets
$86M
$64M
$64M
$23M
$19M
$22M
$25M
$29M
$50M
$34M
$38M
$41M
$44M
$52M
$85M
$99M
Accounts Payable
$3M
$3M
$3M
$2M
$1M
$614.0K
$855.0K
$358.0K
$1M
$2M
$2M
$2M
$2M
$4M
$5M
$4M
Accrued Liabilities
$2M
$2M
$850.0K
$1M
$1M
$2M
$1M
$2M
$4M
$4M
$3M
$5M
$4M
$5M
$3M
$4M
Short-term Debt
·
·
$706.0K
$766.0K
$824.0K
$237.0K
$227.0K
$218.0K
$13M
$13M
$13M
·
$14M
$16M
$22M
$22M
Current Liabilities
$7M
$6M
$6M
$6M
$5M
$5M
$3M
$4M
$21M
$22M
$21M
$22M
$22M
$28M
$32M
$30M
Capital Leases
$2M
$2M
$2M
$2M
$2M
$2M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$4M
Total Liabilities
$8M
$8M
$8M
$8M
$8M
$8M
$7M
$7M
$25M
$25M
$24M
$26M
$27M
$33M
$36M
$36M
Total Debt
·
·
$706.0K
·
$824.0K
$237.0K
$227.0K
·
$13M
$13M
$13M
·
$14M
$16M
$22M
·
Common Stock
$35.0K
$30.0K
$20.0K
$19.0K
$10.0K
$9.0K
$9.0K
$9.0K
$9.0K
$30.0K
$28.0K
$1.0K
$16.0K
$12.0K
$9.0K
$9.0K
Retained Earnings
$-355M
$-347M
$-338M
$-332M
$-327M
$-322M
$-318M
$-314M
$-306M
$-303M
$-295M
$-289M
$-283M
$-276M
$-242M
$-224M
AOCI
$-21.0K
$10.0K
$-15.0K
·
·
·
·
·
·
·
·
·
·
$-167.0K
$-223.0K
$-213.0K
Stockholders' Equity
$78M
$57M
$56M
$15M
$11M
$14M
$18M
$21M
$25M
$9M
$13M
$15M
$17M
$19M
$48M
$63M
Liabilities + Equity
$86M
$64M
$64M
$23M
$19M
$22M
$25M
$29M
$50M
$34M
$38M
$41M
$44M
$52M
$85M
$99M
Shares Outstanding
34,543,561
30,053,070
20,254,599
19,349,201
10,066,276
9,167,670
8,637,895
8,623,676
8,517,449
3,243,725
27,653,582
1,015,505
12,368,287
12,368,287
9,006,582
8,727,158
현금 흐름10
IBIO의 분기별 현금 흐름 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Stock-based Comp
$377.0K
$253.0K
$323.0K
$270.0K
$370.0K
$475.0K
$415.0K
$360.0K
$457.0K
$456.0K
$765.0K
$446.0K
$2M
$1M
$1M
$1M
Amort. of Intangibles
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$49.0K
$67.0K
$68.0K
Operating Cash Flow
$-6M
$-5M
$-6M
$-5M
$-3M
$-4M
$-4M
$-5M
$-4M
$-5M
$-5M
$-5M
$-4M
$-8M
$-14M
$-12M
CapEx
$11.0K
$516.0K
$32.0K
$1.0K
$14.0K
$1.0K
$0
$210.0K
$0
·
·
$506.0K
$-201.0K
$3M
$2M
$3M
Investing Cash Flow
$-3M
$-3M
$-21M
$45.0K
$-14.0K
$-2.0K
$713.0K
$-144.0K
$1M
$0
$50.0K
$-6.0K
$8M
$-1M
$29.0K
$477.0K
Stock Issued
$3M
$0
$219.0K
$2M
$1M
$0
$4.0K
$14M
$4M
$4M
$3M
·
·
·
·
·
Net Stock Activity
·
·
$219.0K
·
·
·
$4.0K
·
·
·
·
·
·
·
·
·
Financing Cash Flow
$28M
$9M
$47M
$8M
$1M
$-152.0K
$-162.0K
$13M
$5M
$4M
$2M
$3M
$1M
$-3M
$1M
$-10.0K
Net Change in Cash
$19M
$561.0K
$20M
$4M
$-2M
$-4M
$-3M
$8M
$2M
$-701.0K
$-3M
$-2M
$6M
$-12M
$-13M
$-11M
Free Cash Flow
·
·
$-6M
·
·
·
·
·
·
·
·
·
·
·
$-16M
·
수익성5
IBIO의 분기별 수익성 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Operating Margin
·
·
-5951.0%
·
·
-2209.5%
·
·
·
·
-10206.0%
·
·
·
·
·
Net Margin
·
·
-5720.0%
·
·
-2182.0%
·
·
·
·
-11492.0%
·
·
·
·
·
EBITDA Margin
·
·
-5951.0%
·
·
-2209.5%
·
·
·
·
-10206.0%
·
·
·
·
·
ROA
-14.7%
-20.9%
-12.9%
·
-14.0%
-15.7%
-12.8%
·
-6.7%
-19.1%
-9.4%
·
-9.1%
-37.6%
-15.9%
·
ROE
-17.4%
-25.5%
-15.5%
·
-26.8%
-37.8%
-25.8%
·
-15.0%
-58.6%
-18.7%
·
-15.1%
-61.3%
-24.3%
·
유동성 및 지급능력4
IBIO의 분기별 유동성 및 지급능력 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Current Ratio
11.9
9.0
8.4
·
1.1
1.8
3.4
·
1.7
0.9
1.1
·
1.2
1.4
2.0
·
Quick Ratio
7.3
4.9
4.7
·
0.9
1.5
3.2
·
0.2
0.1
0.1
·
0.3
0.2
0.3
·
Debt / Equity
·
·
0.0
·
0.1
0.0
0.0
·
0.5
1.4
1.0
·
0.8
0.9
0.5
·
Interest Coverage
·
·
·
·
·
·
·
·
-69.7
-132.2
-196.3
·
-176.3
-341.1
·
·
효율성2
IBIO의 분기별 효율성 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Asset Turnover
·
0.0
0.0
·
0.0
0.0
0.0
·
·
·
0.0
·
0.0
0.0
0.0
·
Receivables Turnover
·
·
3.1
·
·
·
·
·
·
·
0.1
·
0.0
0.0
0.0
·
주당5
IBIO의 분기별 주당 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Book Value / Share
$2.24
$1.88
$2.77
·
$1.13
$1.52
$2.06
·
$2.92
$2.84
$0.48
·
$1.41
$1.52
$5.37
·
Revenue / Share
·
$0.00
$0.00
·
$0.00
$0.02
$0.00
·
·
·
$0.00
·
$0.00
$0.00
$0.00
·
Cash Flow / Share
·
·
$-0.11
·
·
·
$-0.43
·
·
·
$-0.22
·
·
·
$-1.58
·
Cash / Share
$1.38
$0.95
$1.39
·
$0.49
$0.77
$1.28
·
$0.62
$0.86
$0.05
·
$0.53
$0.30
$1.10
·
EPS (TTM)
$-0.75
$-1.17
$-1.54
·
$-2.28
$-6.21
$-10.53
·
$-21.14
$-88.72
$-86.35
·
$-82.97
$-73.27
$-7.24
·
가치 평가 (TTM)14
IBIO의 분기별 가치 평가 (TTM) 데이터
지표
추세
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Revenue TTM
$300.0K
$300.0K
$300.0K
·
·
·
·
·
$50.0K
$50.0K
$50.0K
·
$2M
$2M
$2M
·
Net Income TTM
$-27M
$-24M
$-19M
·
$-16M
$-20M
$-21M
·
$-24M
$-55M
$-65M
·
$-71M
$-76M
$-51M
·
Market Cap
$66M
$58M
$17M
·
$40M
$22M
$19M
·
$35M
$4M
$166M
·
$515M
$109M
$766M
·
Enterprise Value
·
·
$-11M
·
$36M
$16M
$8M
·
$42M
$14M
$177M
·
$522M
$121M
$778M
·
P/E
-2.5
-1.6
-0.5
·
-1.8
-0.4
-0.2
·
-0.2
-0.0
-0.1
·
-0.5
-0.1
-11.7
·
P/S
218.8
193.3
56.0
·
·
·
·
·
691.6
88.9
3318.4
·
285.8
60.5
406.3
·
P/B
0.8
1.0
0.3
·
3.6
1.6
1.1
·
1.4
0.5
12.6
·
29.6
5.8
15.8
·
P / Tangible Book
0.9
1.1
0.3
·
7.7
2.9
1.5
·
1.8
1.2
21.2
·
42.9
8.1
18.1
·
P / Cash Flow
·
·
-3.0
·
·
·
-5.2
·
·
·
-31.1
·
·
·
-54.8
·
P / FCF
·
·
-3.0
·
·
·
·
·
·
·
·
·
·
·
-46.6
·
EV / EBITDA
·
·
1.8
·
-7.4
-3.5
-2.0
·
-11.6
-3.2
-34.7
·
-84.6
-11.5
-101.9
·
EV / FCF
·
·
1.9
·
·
·
·
·
·
·
·
·
·
·
-47.3
·
EV / Revenue
·
·
-35.3
·
·
·
·
·
838.7
286.2
3541.7
·
289.8
67.3
412.9
·
Earnings Yield
-39.5%
-60.6%
-185.5%
·
-56.7%
-253.5%
-474.3%
·
-520.7%
-6475.9%
-1439.2%
·
-199.4%
-832.6%
-8.5%
·
재무제표
손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
매출
$400.0K
$225.0K
$0
$2M
$2M
매출 총이익률 %
—
—
—
90.9%
38.3%
영업이익률 %
-4650.5%
-7392.9%
—
-2085.2%
-1312.1%
순이익
$-18M
$-25M
$-65M
$-50M
$-23M
희석 EPS
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
대차대조표
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
부채 / 자기자본 비율
0.1
0.0
0.8
0.3
0.0
유동비율
1.6
4.1
1.2
1.5
15.7
당좌 비율
1.4
3.7
0.2
0.8
11.7
현금 흐름
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
잉여현금흐름
$-15M
$-19M
$-36M
$-45M
$-35M
나의 지표
나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F)
60개의 제출자 · $59.4M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
신규 포지션
청산 포지션
증가함
감소
순주식 변동
19
(+6 이전 분기 대비)
12
(+1 이전 분기 대비)
18
(+4 이전 분기 대비)
9
(+1 이전 분기 대비)
+16.7M
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황
3 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.